A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
Clinical trial NCT02158091 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02158091
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-27
- Primary completion
- 2017-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.